Skip to main content
. Author manuscript; available in PMC: 2022 Aug 15.
Published in final edited form as: Psychol Addict Behav. 2018 Mar 29;32(3):277–288. doi: 10.1037/adb0000355

Table 1.

Lifetime Alcohol and Drug Use Disorders and Adherence and PTSD Severity Outcomes

No AUD or Drug Dx
(SCID-IV)
n = 108a
M (SD) or %
AUD Dx Only
(SCID-IV)
n = 31a
M (SD) or %
Drug Dx Only
(SCID-IV)
n = 23
M (SD) or %
AUD and Drug Dx
(SCID-IV)
n = 38a
M (SD) or %
Drop Out 24.1% 32.3% 30.4% 55.3%
Adherence
  Sertraline (mean) 2.15 (0.92) 2.26 (1.49) 1.82 (0.67) 2.37 (1.39)
  PE In vivo (mean) 3.02 (1.16) 2.85 (0.97) 2.76 (1.27) 2.75 (1.09)
  PE Imaginal (mean) 2.64 (1.01) 2.82 (0.99) 2.25 (1.19) 2.27 (1.09)
PTSD Severity (PSS-I)
  Pre-treatment 29.00 (6.70) 28.00 (5.33) 29.17 (7.24) 32.71 (6.56)
  Post-treatment 9.85 (8.79) 12.67 (11.26) 9.56 (8.79) 18.28 (13.41)
  6-month follow-up 6.97 (7.43) 7.53 (8.63) 12.44 (11.79) 14.29 (12.02)
  Pre- to 6-month 3.11 2.86 1.71 1.90
  ES (Cohen's d)

Note. AUD = Alcohol Use Disorder; SUD = Substance Use Disorder. SCID = Structured Clinical Interview for DSM-IV Lifetime Diagnosis. PSS-I = Posttraumatic Symptom Scale–Interview. Means are original data, not imputed values. Effect sizes for PTSD severity were calculated using pooled means and standard deviations.

a

Sample size varied for this predictor, with one participant missing alcohol use diagnoses on the SCID at baseline.